Cleveland, MS13 Active Studies

Parkinsons Disease Clinical Trials in Cleveland, MS

Find 13 actively recruiting parkinsons disease clinical trials in Cleveland, MS. Connect with local research sites and explore new treatment options.

13
Active Trials
8
Sponsors
3,374
Enrolling

Recruiting Parkinsons Disease Studies in Cleveland

About Parkinsons Disease Clinical Trials in Cleveland

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 13 parkinsons disease clinical trials recruiting participants in Cleveland, MS. These studies are seeking a combined 3,374 participants. Research is being sponsored by Michael J. Fox Foundation for Parkinson's Research, JHSPH Center for Clinical Trials, Jay Alberts and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Cleveland — FAQ

Are there parkinsons disease clinical trials in Cleveland?

Yes, there are 13 parkinsons disease clinical trials currently recruiting in Cleveland, MS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cleveland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cleveland research site will contact you about next steps.

Are clinical trials in Cleveland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cleveland studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 13 active trials in Cleveland are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 13, 2026 from ClinicalTrials.gov